Heparin Anticoagulant for Human Bone Marrow Does Not Influence In Vitro Performance of Human Mesenchymal Stromal Cells
Mesenchymal stromal cells (MSCs) are a promising cell source for tissue engineering and regenerative medicine. In our lab, we found that MSC preparations from bone marrow of many different donors had a limited capacity of in vitro differentiation into osteogenic and chondrogenic lineages—a capacity...
Main Authors: | Yvonne Roger, Laura Burmeister, Anika Hamm, Kirsten Elger, Oliver Dittrich-Breiholz, Thilo Flörkemeier, Andrea Hoffmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/7/1580 |
Similar Items
-
IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?
by: Fahad Al-Eidan
Published: (2015-04-01) -
Inactivation of Heparin by Cationically Modified Chitosan
by: Barbara Lorkowska-Zawicka, et al.
Published: (2014-06-01) -
Does ‘heparin-induced thrombocytopenia’ hit our minds?
by: Arun R. Thangavel, et al.
Published: (2016-08-01) -
Comparison of Two Nomograms of Unfractionated Heparin in Patients with Acute Coronary Syndrome
by: Moneyreh Modares Mosadegh, et al.
Published: (2013-02-01) -
Comparison of Two Nomograms of Unfractionated Heparin in Patients with Acute Coronary Syndrome
by: Moneyreh Modares Mosadegh, et al.
Published: (2013-02-01)